Avai Bio (AVAI) Assets Average (2018 - 2025)
Avai Bio's Assets Average history spans 7 years, with the latest figure at $306630.0 for Q1 2024.
- On a quarterly basis, Assets Average rose 16.51% to $306630.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $306630.0, a 16.51% increase, with the full-year FY2024 number at $281737.0, down 19.06% from a year prior.
- Assets Average hit $306630.0 in Q1 2024 for Avai Bio, up from $278153.5 in the prior quarter.
- Over the last five years, Assets Average for AVAI hit a ceiling of $725250.5 in Q4 2020 and a floor of $257939.5 in Q2 2023.
- Historically, Assets Average has averaged $425815.6 across 5 years, with a median of $337753.5 in 2022.
- Biggest five-year swings in Assets Average: soared 3214.07% in 2020 and later crashed 58.59% in 2023.
- Tracing AVAI's Assets Average over 5 years: stood at $725250.5 in 2020, then changed by 0.0% to $725250.5 in 2021, then tumbled by 57.01% to $311768.0 in 2022, then dropped by 10.78% to $278153.5 in 2023, then grew by 10.24% to $306630.0 in 2024.
- Business Quant data shows Assets Average for AVAI at $306630.0 in Q1 2024, $278153.5 in Q4 2023, and $269740.0 in Q3 2023.